Advice and dissemination
For Bioithas, disseminating knowledge to specialists and users is a fundamental objective that will allow us to continue advancing thanks to knowing the existing concerns of the population.
Our experience in research in the field of human microbiota and probiotics, both in the public and private sectors, has allowed us to act, especially the founder and Scientific Director of Bioithas, Dr. Vicente Navarro, as scientific advisors. of various companies and pharmaceutical companies and the food sector for the development of their new products and R&D projects.
All this has given us great experience in the field of scientific dissemination in our field of research, giving talks and presentations at many national and international congresses and conferences, research centers, and hospitals and private clinics.
Our accreditations
If you want more information
Fill in your information and we will contact you.
The personal data contained in the query will be processed by BIOITHAS, SL and incorporated into the CONTACTS processing activity, the purpose of which is to attend to your requests, requests or queries received from the web, by email or telephone. Respond to your request and follow up later.
The legitimacy of the treatment is your consent. Your data will not be disclosed to third parties. You have the right to access, rectify and delete your data, as well as other rights as explained in our privacy policy: https://www.adelopd.com/privacidad/bioithas-sl
It may interest you
Scientific articles
Below, we detail the scientific articles published and led by our scientific director Vicente Navarro López, in several of the most important indexed journals in the world:
Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile
Microorganisms, 2021; 9(8):1727. doi: 10.3390/microorganisms9081727.
Probiotics in the Therapeutic Arsenal of Dermatologists
Microorganisms, 2021; 9(7):1513. doi: 10.3390/microorganisms9071513.
Study of the Vaginal Microbiota in Healthy Women of Reproductive Age
Microorganisms, 2021; 9(5):1069. doi: 10.3390/microorganisms9051069.
Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial.
Microorganisms, 2021; 9(4): 854, doi: 10.3390/microorganisms9040854.
Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: a Randomized Clinical Trial.
Dermato-Venereological Act, 2019; 99(12): 1078-1084, doi:10.2340/00015555-3305.
Gut microbial composition in patients with psoriasis.
Scientific Reports, 2018; 8(1): 3812, doi: 10.1038/s41598-018-22125-y.
OTHERS
Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial . JAMA Dermatology, 2018; 154(1): 37–43, doi: 10.1001/jamadermatol.2017.3647.
Identification of Bacterial DNA in the Peripheral Blood of Patients With Active Psoriasis. JAMA Dermatology, 2015; 151(6): 670-1, doi: 10.1001/jamadermatol.2014.5585.
Reducing test request for anti-thyroglobulin and anti-thyroid peroxidase antibodies: trends before and after interventions based on rejection rules and profile management. Medical biochemistry. 28-3, p. https://doi.org/10.11613/BM.2018.030709. Croatian Society of Medical Biochemistry and Laboratory Medicine, 01/10/2018
Scientific experience supports us , and you can count on us.
The intestinal microbiota as a new prognostic factor in relapsing-remitting multiple sclerosis. “LXXII Annual Meeting of the Spanish Society of Neurology”, 11/23/2020 – 12/03/2020.
The salivary microbiota as a proposed diagnostic biomarker in head and neck cancer. “XI Workshop of the Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP)”. Grenada, 02/7/2020 – 02/9/2020.
A new target for the treatment of acne vulgaris. Research pilot study. AEDV 2019, 47th National Congress of Dermatology and Venereology. Barcelona, 06/05/2019 – 06/08/2019.
Randomized double-blind placebo-controlled clinical trial to evaluate the safety and effect of a probiotic mixture on the PASI index in patients with moderate psoriasis . AEDV 2018, 46th National Congress of Dermatology and Venereology. Palma de Mallorca, 09/0/2018 – 05/12/2018.
Alpha diversity study in patients with Clostridium difficile infection and asymptomatic carriers. X Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Las Palmas de Gran Canaria, 02/06/2019 – 02/08/2019 Spanish Society of Probiotics and Prebiotics (SEPyP).
Gut microbiota as a new predictive factor in active relapsing-remitting multiple sclerosis. X Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP) Las Palmas de Gran Canaria, 02/06/2019 - 02/08/2019 Spanish Society of Probiotics and Prebiotics (SEPyP).
XXII Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology 2018. Bilbao, 05/24/2018 - 05/26/2018 Spanish Society of Infectious Diseases and Clinical Microbiology.
Study of the intestinal microbiota in patients with moderate atopic dermatitis. XXII Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology 2018. Bilbao, 05/24/2018 - 05/26/2018. Spanish Society of Infectious Diseases and Clinical Microbiology.
Study of the intestinal microbiota in patients with psoriasis. XXII Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology 2018. Bilbao, 05/24/2018 - 05/26/2018. Spanish Society of Infectious Diseases and Clinical Microbiology.
Probiotics in atopic dermatitis: a new line of treatment. VIII National Congress of Community Pharmacists. Alicante, 05/24/2018. Spanish Society of Family and Community Pharmacy.
A randomized clinical trial to evaluate the safety and the effect of a probiotic mixture on PASI index in patients with moderate psoriasis. IX Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Zaragoza, 02/15/2018 - 02/16/2018. Spanish Society of Probiotics and Prebiotics (SEPyP)
Microbiome core in patients with Relapsing-Remitting Multiple Sclerosis. IX Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Zaragoza, 02/15/2018 - 02/16/2018. Spanish Society of Probiotics and Prebiotics (SEPyP). Correspondence author.
Effect of treatment with an oral probiotic on the symptoms of atopic dermatitis in children and its effect on the composition of the intestinal microbiome. AEDV 2017, 45th National Congress of Dermatology and Venereology. Madrid, 05/10/2017 - 05/13/2017. Spanish Academy of Dermatology and Venereology.
Oral treatment with a mixture of probiotics reduces the SCORAD index and the use of topical corticosteroids in young patients with atopic dermatitis . Randomized clinical trial. VIII
2019 Research Patronage Award. Awarded by the Social Council of the University of Alicante.
National Research Award, Pfizer Chair of Psoriasis, Autonomous University of Madrid 2015. Bacterial Translocation in a case series of patients with psoriasis.
Best Research Project by the Spanish Society of Dermatology in 2015. Bacterial Translocation in a case series of patients with psoriasis.
Accesit to the best national clinical research work with the use of probiotics. Atopic dermatitis. A randomized Clinical Trial. National Congress of the Spanish Society of Probiotics and Prebiotics. Workshop SEPYP 2017
National Award for the best clinical research work with oral communication. Psoriasis. A randomized Clinical trial. National Congress of the Spanish Society of Probiotics and Prebiotics, Workshop SEPYP 2018
Award for the best Oral Communication for clinical uses. Multiple sclerosis and microbiota. Original Investigation. Spanish Society of Probiotics and Prebiotics, Workshop SEPYP 2019.
National Award: accesit to the best work in poster format. Differences in the intestinal microbiota of asymptomatic and symptomatic carrier patients with clostridium difficile infection. Study of a cohort of patients.